These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 717388)
1. Accumulation modes of alkylating agents on normal peripheral blood lymphocytes. Brody JI Am J Hematol; 1978; 4(3):245-54. PubMed ID: 717388 [TBL] [Abstract][Full Text] [Related]
2. Differential uptake of alkylating agents by normal and leukemic lymphocytes. Brody JI Cancer; 1975 Dec; 36(6):1959-65. PubMed ID: 1106834 [TBL] [Abstract][Full Text] [Related]
3. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen]. Höffken K; Ippisch A; Pfeiffer R; Becher R; Seeber S; Schmidt CG Dtsch Med Wochenschr; 1985 Apr; 110(16):618-23. PubMed ID: 3838719 [TBL] [Abstract][Full Text] [Related]
5. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137 [TBL] [Abstract][Full Text] [Related]
6. Advances in chemotherapy for large cell lymphoma. Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a transport carrier of nitrogen mustard in nitrogen mustard-sensitive and -resistant L5178Y lymphoblasts. Goldenberg GJ; Vanstone CL; Israels LG; Iise D; Bihler I Cancer Res; 1970 Sep; 30(9):2285-91. PubMed ID: 5475476 [No Abstract] [Full Text] [Related]
8. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease. Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125 [TBL] [Abstract][Full Text] [Related]
9. [The effect of alkylating agents on DNA, RNA and protein synthesis by leukemic lymphocytes in vitro]. Foldesh J; Djaldetti M Harefuah; 1979 Feb; 96(3):139-40. PubMed ID: 488806 [No Abstract] [Full Text] [Related]
10. Drug-induced stimulation of transport of hydrolyzed nitrogen mustard and choline by normal and leukemic human cells in vitro. Goldenberg GJ Cancer Res; 1976 Mar; 36(3):978-82. PubMed ID: 1062233 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of neutrophil chemotaxis by 4-hydroxycyclophosphamide. Gilbert DN; Starr P; Eubanks N Cancer Res; 1977 Feb; 37(2):456-9. PubMed ID: 832269 [TBL] [Abstract][Full Text] [Related]
12. Unscheduled DNA synthesis in spermatogenic cells of mice treated in vivo with the indirect alkylating agents cyclophosphamide and mitomen. Sotomayor RE; Sega GA; Cumming RB Mutat Res; 1978 May; 50(2):229-40. PubMed ID: 651938 [No Abstract] [Full Text] [Related]
13. Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors. Salas C; Niembro A; Lozano V; Gallardo E; Molina B; Sánchez S; Ramos S; Carnevale A; Pérez-Vera P; Rivera Luna R; Frias S Environ Mol Mutagen; 2012 May; 53(4):271-80. PubMed ID: 22434555 [TBL] [Abstract][Full Text] [Related]
14. Dose-Effect Relationship of Alkylating Agents on Testicular Function in Male Survivors of Childhood Lymphoma. Servitzoglou M; De Vathaire F; Oberlin O; Patte C; Thomas-Teinturier C Pediatr Hematol Oncol; 2015; 32(8):613-23. PubMed ID: 26561347 [TBL] [Abstract][Full Text] [Related]
15. The role of drug transport in resistance to nitrogen mustard and other alkylating agents in L518Y lymphoblsts. Goldenberg GJ Cancer Res; 1975 Jul; 35(7):1687-92. PubMed ID: 1055634 [TBL] [Abstract][Full Text] [Related]
16. A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphoma. Benjamin RS; Wiernik PH; O'Connell MJ; Chang P; Sutherland JC Cancer; 1976 Nov; 38(5):1896-902. PubMed ID: 1036467 [TBL] [Abstract][Full Text] [Related]
17. In vitro effects of single alkylating agents on normal peripheral blood lymphocytes. Brody JI J Lab Clin Med; 1979 Jul; 94(1):114-122. PubMed ID: 469367 [TBL] [Abstract][Full Text] [Related]
18. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727 [TBL] [Abstract][Full Text] [Related]
19. [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)]. Błasińska-Morawiec M; Płuzańska A; Krykowski E; Robak T; Mrówka I Pol Arch Med Wewn; 1991 Oct; 86(4):274-80. PubMed ID: 1813880 [TBL] [Abstract][Full Text] [Related]
20. Acute metabolic effects of nitrogen mustard and thiotepa on rabbit articular cartilage and synovium. Mankin HJ; Lippiello L Arthritis Rheum; 1979 Jun; 22(6):579-85. PubMed ID: 110338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]